Search Results 111-120 of 16960 for Linaclotide

  1. Erlotinib Hydrochloride In Reducing Duodenal Polyp Burden In Patients With Familial Adenomatous Polyposis At Risk Of Developing Colon Cancer - Mayo Clinic

    Erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant ...

  2. Gastroenterology and Hepatology - Clinical trials

    Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...

  3. Gastroenterology and Hepatology - Clinical trials

    Other enteropathies will also be included: collagenous sprue, idiopathic sprue, lymphocytic enterocolitis, idiopathic enteropathies, collagenous gastritis, ...

  4. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic-Led Researchers Confirm Gene Variants Associated With The Most Common Adult Leukemia. September 9, 2010. Health & Wellness.

  5. Clinical trials - Gastroenterology and Hepatology

    Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...

  6. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...

  7. Gastroenterology and Hepatology - Clinical trials

    Other enteropathies will also be included: collagenous sprue, idiopathic sprue, lymphocytic enterocolitis, idiopathic enteropathies, collagenous gastritis, ...

  8. Phase I Study Of LB-100 With Docetaxel In Solid Tumors - Mayo Clinic

    LB-100 is a small molecule that in laboratory and animal studies has shown activity when used by itself or together with drugs approved to treat some types of ...

  9. A Phase 2b, Study Of Linsitinib In Subjects With Active, Moderate To Severe Thyroid Eye Disease (TED) - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of linsitinib. Study drug is administered twice daily for six-months (24 weeks) in ...

  10. A Study To Evaluate Belinostat And Guadecitabine Or ASTX727 To Treat Unresectable And Metastatic Conventional Chondrosarcoma - Mayo Clinic

    Belinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as guadecitabine, work in ...